tradingkey.logo

Biomerica Inc

BMRA
2.480USD
-0.230-8.49%
Close 11/04, 16:00ETQuotes delayed by 15 min
6.98MMarket Cap
LossP/E TTM

Biomerica Inc

2.480
-0.230-8.49%

More Details of Biomerica Inc Company

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Biomerica Inc Info

Ticker SymbolBMRA
Company nameBiomerica Inc
IPO dateMar 17, 1980
CEOMr. Zackary S. Irani
Number of employees53
Security typeOrdinary Share
Fiscal year-endMar 17
Address17571 Von Karman Avenue
CityIRVINE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92614
Phone19493792875
Websitehttps://biomerica.com/
Ticker SymbolBMRA
IPO dateMar 17, 1980
CEOMr. Zackary S. Irani

Company Executives of Biomerica Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
166.63K
--
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
24.53K
--
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
21.25K
--
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
10.00K
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
166.63K
--
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
24.53K
--
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
21.25K
--
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
10.00K
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Clinical Lab
3.18M
59.89%
Contract Manufacturing
1.07M
20.15%
OTC
1.05M
19.75%
Physicians’ Office
11.00K
0.21%
By RegionUSD
Name
Revenue
Proportion
Asia
1.72M
32.35%
United States
1.66M
31.22%
Europe
1.30M
24.42%
Middle East
630.00K
11.86%
South America
8.00K
0.15%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Clinical Lab
3.18M
59.89%
Contract Manufacturing
1.07M
20.15%
OTC
1.05M
19.75%
Physicians’ Office
11.00K
0.21%

Shareholding Stats

Updated: Wed, Oct 22
Updated: Wed, Oct 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Irani (Zackary S)
5.65%
Barbieri (Allen)
1.26%
Emerson (Jane)
1.02%
Lu (Gary)
0.83%
Geode Capital Management, L.L.C.
0.73%
Other
90.49%
Shareholders
Shareholders
Proportion
Irani (Zackary S)
5.65%
Barbieri (Allen)
1.26%
Emerson (Jane)
1.02%
Lu (Gary)
0.83%
Geode Capital Management, L.L.C.
0.73%
Other
90.49%
Shareholder Types
Shareholders
Proportion
Individual Investor
10.38%
Investment Advisor
1.56%
Investment Advisor/Hedge Fund
0.80%
Other
87.26%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
63
90.65K
3.36%
-288.15K
2025Q2
71
405.55K
15.93%
-188.61K
2025Q1
76
410.80K
15.63%
-250.78K
2024Q4
75
3.95M
21.57%
-995.41K
2024Q3
72
3.29M
19.49%
-2.27M
2024Q2
72
4.09M
24.25%
-2.17M
2024Q1
69
5.91M
35.06%
-122.92K
2023Q4
64
5.72M
33.95%
-599.64K
2023Q3
64
6.05M
35.94%
-733.42K
2023Q2
65
6.44M
38.42%
-719.23K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Geode Capital Management, L.L.C.
21.66K
0.75%
+2.09K
+10.68%
Jun 30, 2025
Moatazedi (David)
--
0%
-10.63K
-100.00%
Sep 26, 2025
The Vanguard Group, Inc.
21.13K
0.74%
+1.00
+0.00%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
18.64K
0.65%
+1.00
+0.01%
Jun 30, 2025
Coste (Catherine)
16.10K
0.1%
+10.63K
+194.10%
Dec 13, 2024
Chin (Eric)
10.00K
0.35%
+10.00K
--
Jun 04, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI